These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 192993)

  • 1. Use of (-)-[3H]dihydroalprenolol to study beta adrenergic receptor-adenylate cyclase coupling in C6 glioma cells: role of 5'-guanylylimidodiphosphate.
    Lucas M; Bockaert J
    Mol Pharmacol; 1977 Mar; 13(2):314-29. PubMed ID: 192993
    [No Abstract]   [Full Text] [Related]  

  • 2. Receptor-associated changes of the catecholamine-sensitive adenylate cyclase in glioma cells doubly transformed with Moloney sarcoma virus.
    Higashida H; Miki N; Tanaka T; Kato K; Nakano T; Nagatsu T; Kano-Tanaka K
    J Cell Physiol; 1982 Feb; 110(2):107-13. PubMed ID: 6279681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular pharmacology of adenylate cyclase-coupled alpha- and beta-adrenergic receptors.
    Lefkowitz RJ; De Lean A; Hoffman BB; Stadel JM; Kent R; Michel T; Limbird L
    Adv Cyclic Nucleotide Res; 1981; 14():145-61. PubMed ID: 6269377
    [No Abstract]   [Full Text] [Related]  

  • 4. Agonist- induced transconformation of beta-adrenergic receptors, and adenylate cyclase activation [proceedings].
    Vauquelin G; Bottari S; Strosberg AD
    Arch Int Physiol Biochim; 1979 Oct; 87(4):859-60. PubMed ID: 93949
    [No Abstract]   [Full Text] [Related]  

  • 5. Identity of [3H]-dihydroalprenolol binding sites and beta-adrenergic receptors coupled with adenylate cyclase in the central nervous system: pharmacological properties, distribution and adaptive responsiveness.
    Dolphin A; Adrien J; Hamon M; Bockaert J
    Mol Pharmacol; 1979 Jan; 15(1):1-15. PubMed ID: 218089
    [No Abstract]   [Full Text] [Related]  

  • 6. Identity of [3H]dihydroalprenolol binding sites and beta-2 adrenergic receptors coupled with adenylate cyclase in guinea-pig skeletal muscle sarcolemma: general properties and structure-activity relationships.
    Wei JW; Sulakhe PV
    J Pharmacol Exp Ther; 1980 Jul; 214(1):186-96. PubMed ID: 6104715
    [No Abstract]   [Full Text] [Related]  

  • 7. Pre-steady state study of beta-adrenergic and purinergic receptor interaction in C6 cell membranes: undelayed balance between positive and negative coupling to adenylyl cyclase.
    Valeins H; Merle M; Labouesse J
    Mol Pharmacol; 1992 Dec; 42(6):1033-41. PubMed ID: 1336111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical modification of the beta adrenergic receptors coupled with adenylate cyclase by disulfide bridge-reducing agents.
    Lucas M; Hanoune J; Bockaert J
    Mol Pharmacol; 1978 Mar; 14(2):227-36. PubMed ID: 205769
    [No Abstract]   [Full Text] [Related]  

  • 9. Desensitization of adenylate cyclase and down regulation of beta adrenergic receptors after in vivo administration of beta agonist.
    Scarpace PJ; Abrass IB
    J Pharmacol Exp Ther; 1982 Nov; 223(2):327-31. PubMed ID: 6127402
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desensitization of catecholamine-stimulated adenylate cyclase and down-regulation of beta-adrenergic receptors in rat glioma C6 cells. Role of cyclic AMP and protein synthesis.
    Zaremba TG; Fishman PH
    Mol Pharmacol; 1984 Sep; 26(2):206-13. PubMed ID: 6207420
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Catecholamine-induced desensitization involves an uncoupling of beta-adrenergic receptors and adenylate cyclase.
    Harden TK; Su YF; Perkins JP
    J Cyclic Nucleotide Res; 1979; 5(2):99-106. PubMed ID: 221555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation and characterization of S49 lymphoma cells deficient in beta-adrenergic receptors: relation of receptor number to activation of adenylate cyclase.
    Johnson GL; Bourne HR; Gleason MK; Coffino P; Insel PA; Melmon KL
    Mol Pharmacol; 1979 Jan; 15(1):16-27. PubMed ID: 34089
    [No Abstract]   [Full Text] [Related]  

  • 13. Change of coupling system of receptor-adenylate cyclase induced by epinephrine and GTP in plasma membranes of rat liver.
    Okamura N; Terayama H
    Biochim Biophys Acta; 1978 Nov; 544(1):113-27. PubMed ID: 214146
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple effects of guanosine triphosphate on beta adrenergic receptors and adenylate cyclase activity in rat heart, lung and brain.
    Hegstrand LR; Minneman KP; Molinoff PB
    J Pharmacol Exp Ther; 1979 Aug; 210(2):215-21. PubMed ID: 222893
    [No Abstract]   [Full Text] [Related]  

  • 15. Efficiency of coupling between the beta adrenergic receptor and adenylate cyclase.
    Howlett AC; Van Arsdale PM; Gilman AG
    Mol Pharmacol; 1978 Jul; 14(4):531-9. PubMed ID: 210367
    [No Abstract]   [Full Text] [Related]  

  • 16. Adenylate cyclase and beta adrenergic receptor development in the mouse heart.
    Chen FC; Yamamura HI; Roeske WR
    J Pharmacol Exp Ther; 1982 Jul; 222(1):7-13. PubMed ID: 6283073
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Properties of beta-adrenergic receptors in untreated and butyrate-treated Hela cells.
    Tallman JF; Smith CC; Henneberry RC
    Biochim Biophys Acta; 1978 Jul; 541(3):288-300. PubMed ID: 208639
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catecholamine-induced desensitization of adenylate cyclase in rat glioma C6 cells. Evidence for a specific uncoupling of beta-adrenergic receptors from a functional regulatory component of adenylate cyclase.
    Fishman PH; Mallorga P; Tallman JF
    Mol Pharmacol; 1981 Sep; 20(2):310-8. PubMed ID: 6272090
    [No Abstract]   [Full Text] [Related]  

  • 19. Beta adrenergic receptor repopulation of C6 glioma cells after irreversible blockade and down regulation.
    Homburger V; Pantaloni C; Lucas M; Gozlan H; Bockaert J
    J Cell Physiol; 1984 Dec; 121(3):589-97. PubMed ID: 6094600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of beta adrenergic receptors in isolated frog erythrocyte plasma membranes.
    Mukherjee C; Lefkowitz RJ
    Mol Pharmacol; 1977 Mar; 13(2):291-303. PubMed ID: 16207
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.